CUA Educational Content

Biochemical Recurrence in Prostate Cancer


Featuring: Brita Danielson, Christopher Wallis, Bhimal Bhindi

 
Description: 

  • What is BCR, how to monitor BCR, and when to start ADT
  • Intermittent vs. continuous ADT (and when to switch)
  • Treatment intensification, and when to refer patient to an oncologist
  • Current studies looking at treatment intensification for BCR (prior to development of nmCRPC)
Start Quiz for Credits

 

This program has received financial support from Bayer in the form of an educational grant.

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy